NASDAQ Biotechnology
NBI
6,025.16
124.92
2.12%
NASDAQ Biotechnology
The NASDAQ Biotechnology Index contains securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria. The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology.
The Index began on November 1, 1993 at a base value of 200.00.
| Last | 6,025.16 |
| Net Change | 124.92 |
| Net Change(%) | 2.12% |
| Day High | 6,025.16 |
| Day Low | 5,900.25 |
| Previous Close | 6,025.16 |
| Base Value | 200.00 |
| Divisor | 255,144,526 |
| Name | Symbol | Sponsor |
|---|---|---|
| ProShares Ultra NASDAQ Biotechnology ETF | BIB |
ProShares Trust
|
| ProShares UltraShort NASDAQ Biotechnology ETF | BIS |
ProShares Trust
|
| Invesco Nasdaq Biotechnology ETF | IBBQ |
Invesco
|
| Invesco NASDAQ Biotech UCITS ETF | SBIO |
Invesco PowerShares
|
| Tin'Koff Nasdaq Biotech | TBIO |
Tinkoff Capital
|
| Capital NASDAQ Biotechnology Index Exchang Traded Fund | 678 |
Capital Securities Inv Tst Co.
|
| China Universal NASDAQ Biotechnology ETF QDII Fund | 513290 CH |
China Universal Asset Management
|
| Mirae Asset TIGER Nasdaq BIO ETF | 203780 |
Mirae Asset MAPS Global Investment Co., Ltd
|
| Name | Symbol | Sponsor |
|---|---|---|
| KSM ETF (4A) NASDAQ Biotechnology Currency Hedged | KSMF168 |
KSM Mutual Funds Ltd
|
| TachSAL(4A) Comp S&PHealth(70%)NAS BIO(30%) Currency Hedged | TCHF53 |
Meitav Tachlit Mutual Funds Ltd.
|
| Nasdaq Biotechnology Index Mother Fund | 04312181- |
Daiwa Asset Management Co. Ltd.
|
| Tachlit SAL (4A) NASDAQ Biotechnology Currency-Hedged | TCHF142 |
Meitav Tachlit Mutual Funds Ltd.
|
| Tachlit SAL (4D) NASDAQ Biotechnology | TCHF80 |
Meitav Tachlit Mutual Funds Ltd.
|